U.S. Food and Drug Administration Approves Portola Pharmaceuticals’ Prior Approval Supplement for Andexxa

Portola Pharmaceuticals (Nasdaq:PTLA) announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s Prior Approval Supplement (PAS)...

U.S. FDA Assigns PDUFA Date to Portola Pharmaceuticals’ Prior Approval Supplement for the Large-Scale Generation 2 Andexxa Process

Portola Pharmaceuticals (Nasdaq:PTLA) announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the Company’s Prior Approval Supplement...